no image available Dickens & Co. "A Beacon of Hope: EMA Clears Ofatumumab for Treatment of Relapsed CLL" "Breakthrough therapy offers new hope for patients with chronic lymphocytic leukemia (CLL) who have exhausted all other treatment options" Price: 18.00€